News
Advertisement
Advertisement
Advertisement
Protecting Subjects: The IRBs Next Steps
Advertisement
SITES : Incorporating Standard of Care in Study Budgets Benefits of CTMS at the Investigative Site Also in this issue : FDA Transparency Efforts to Impact Research, Survey Assesses Europe?s Clinical Trials Directive, Tapping into the Potential of Pharmacists, Biosimilars Make Headway in the U.S.
Updates on Osteoporosis including Amgen and Prolia trials.
Act cover
Do Sites Prefer a Sponsor Company or CRO to Run Their Clinical Trial?
Industry news focusing on the people and organizations who work in the clinical trials profession.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data
2
Measuring Barriers to Improve Enrollment and Retention
3
ACT Brief: Support Services and Cancer Trial Access, 2025’s Most-Watched ACT Video Interviews, and FDA Approval of Narsoplimab
4
Our Top 5 Most Viewed Video Interviews in 2025
5